NRC Publishes Proposed Rule for Medical Events
NRC has published for comment a proposed rule covering medical events for brachytherapy, training and establishment of Associate RSO.
FDA Publishes Draft Informed Consent Guidance
The FDA has published a draft version of proposed guidance for “Informed Consent” for all IRB’s and research uses of FDA regulated entities. Comment period expires September 15, 2014.
TJC DELAYS Implementation of Diagnostic Imaging Standards to July 1, 2015
Due to stakeholder feedback, which now requires further research, The Joint Commission (TJC) has delayed the implementation date for it’s revised Diagnostic Imaging Standards to July 1, 2015.
RSO Update Course – October 2015
Medical Physics Consultants, Inc is offering a RSO Update Course at our Ann Arbor office October 19-23, 2015. To Hold your spot, a deposit of $500 is required. For more information, please contact Tracy King at [email protected] or 734.662.3197.
MITA Introduces “Imaging Forward”
The Medical Imaging & Technology Alliance (MITA) has introduced an “Imaging Forward” campaign to note how innovative as well as the effects on health care of recent and forthcoming advances in medical imaging.
Cardiologists Urged to Counsel Patients if Dose Greater than 20 mSv
Cardiologists Urged to Counsel Patients if Dose Greater than 20 mSv – The Journal of the American College of Cardiology (JACC) has recommended that cardiologists educate patients if procedures will result in a dose greater than 20 mSv. Doses less than 3 mSv would not require counseling.
CMS Eliminates “Direct Supervision” Requirement
CMS has eliminated the burdensome requirement of “Direct Supervision” by a physician / pharmacist of NMT’s compounding radiopharmaceuticals. 02-09-14
Dose Reduction in DSA and Fluoroscopy Webinar
On 02/13/14 Philips is sponsoring a CME Catagory I webinar on Radiation Dose Reduction in DSA & Fluoroscopy.
Effective Patient Communication of Cardiac Radiation Risks
The European Heart Journal has published an article that stresses the need for effective communication of radiation risks from cardiac procedures to patients pre-procedure.
New PET Cardiac Agents on the Horizon
FluoroPharma Medical, Inc released information about BFPET (Blood Flow PET) a positively charged lipid compound, much like Lantheus’s Flupiridaz. Additionally a fatty acid imaging agent CardioPET was also introduced.
